CIK 0002022416 · <br>Emerging growth company
Silexion Therapeutics Corp
Sign in to watch- Ticker
- SLXN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- operating
- Phone
- 972-8-6286005
- Business address
- 12 ABBA HILLEL ROAD, RAMAT GAN, Israel, 5250606
- Former names
- Biomotion Sciences
Securities
- SLXN Ordinary Shares Nasdaq
- SLXNW Warrant Nasdaq
- CORRESP Other Correspondence Between Filers and SEC Staff
- PRE 14A Proxy Proxy Statement (Preliminary)
- S-1 Offering Registration Statement
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure · Other events
- 424B3 Offering Prospectus
- 8-K Event Executive or director change
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-1 Offering Registration Statement
- 8-K Event Regulation FD disclosure
- 10-Q Report Quarterly Report
- SC 13D Stake Beneficial Ownership Report
- SC 13D Stake Beneficial Ownership Report
- 8-K Event Material agreement · Acquisition or sale completed · New debt or obligation · Unregistered share sale · Shareholder rights changed · Change in control · Executive or director change · Bylaws or fiscal year change · Code of ethics change · Shell status change · Regulation FD disclosure
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 13 of 15 · 283 filings